Names
Mozobil® PlerixaforIndications and usage
Plerixafor injection is FDA approved for use along with a granulocyte colony-stimulating factor (G-CSF) medication in preparation for an autologous stem cell transplant in patients with non-Hodgkin lymphoma or myeloma. Plerixafor injection works by causing certain blood cells to move from the bone marrow to the blood so that they can be removed for transplantation.
Side effects needing medical attention
Diarrhea; nausea; tiredness (fatigue); injection site reaction; headache; pain in the joints (arthralgia); dizziness; vomiting.